Brandinium

Trademark search for:

ABONT SYRINGE

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 2021-01-09 — Application filed
  • 2021-02-25 — Sn assigned for sect 66a appl from ib
  • 2021-03-01 — Application filed
  • 2021-03-05 — Application filed
  • 2021-03-18 — Teas change of owner address received
  • 2021-03-18 — Teas revoke/app/change addr of atty/dom rep received
  • 2021-03-18 — Attorney/dom.rep.revoked and/or appointed
  • 2021-03-18 — Teas change of domestic representatives address
  • 2021-03-18 — Teas change of correspondence received
  • 2021-03-18 — Applicant/correspondence changes (non-responsive) entered
  • 2021-07-19 — Assigned to examiner
  • 2021-08-04 — Final disposition recorded
  • 2021-08-05 — Office action issued
  • 2021-08-16 — Office action issued
  • 2021-08-16 — Office action issued
  • 2021-09-05 — Office action issued
  • 2021-09-08 — Office action issued
  • 2021-09-08 — Correspondence received in law office
  • 2021-09-09 — Teas/email correspondence entered
  • 2021-09-30 — Suspension letter written
  • 2021-09-30 — Letter of suspension e-mailed
  • 2021-09-30 — Notification of letter of suspension e-mailed
  • 2022-03-30 — Report completed suspension check case still suspended
  • 2022-07-27 — Notification of possible opposition created, to be sent to ib
  • 2022-07-27 — Notification of possible opposition sent to ib
  • 2022-07-29 — New representative at ib received
  • 2022-08-19 — Change of name/address rec'd from ib
  • 2022-09-04 — Notification of possible opposition - processed by ib
  • 2022-10-05 — Report completed suspension check case still suspended
  • 2023-04-04 — Report completed suspension check case still suspended
  • 2023-11-12 — Report completed suspension check case still suspended
  • 2024-05-15 — Suspension checked - to attorney for action
  • 2024-05-16 — Report completed suspension check case still suspended
  • 2024-10-09 — Teas response to suspension inquiry received
  • 2024-11-15 — Teas change of owner address received
  • 2024-11-15 — Applicant/correspondence changes (non-responsive) entered
  • 2024-11-15 — Teas revoke/app/change addr of atty/dom rep received
  • 2024-11-15 — Attorney/dom.rep.revoked and/or appointed
  • 2024-11-15 — Teas withdrawal as domestic representative received
  • 2024-11-15 — Teas change of domestic representatives address
  • 2024-11-15 — Teas change of correspondence received
  • 2024-12-17 — Assigned to lie
  • 2024-12-17 — Correspondence received in law office
  • 2024-12-17 — Teas/email correspondence entered
  • 2024-12-17 — Application abandoned
  • 2024-12-17 — Application abandoned
  • 2024-12-17 — Final status recorded
  • 2024-12-20 — New representative at ib received
  • 2025-12-17 — Final disposition recorded
  • 2025-12-17 — Final disposition recorded
  • 2026-01-01 — Final disposition recorded

Owner Information

Galderma S.A.
CH

Correspondent

Katherine P. Califa Foley & Lardner LLP
3000 K Street, N.W. Suite 600
Washington, DC 20007-5109
United States

Filing Details

Filing Date:
2021-01-09
Status Date:
2024-12-17
Category:
Pharmaceuticals
Filing Year:
2021

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.